Ozempic and Wegovy force weight loss companies to upend their approaches

  • 📰 NBCNews
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 86%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

The growing popularity of obesity and diabetes drugs Wegovy and Ozempic is inspiring other weight-loss companies to fundamentally shift their business models.

, a telehealth company that offers prescriptions for obesity drugs. In the coming months, WeightWatchers said it would roll out a program for members taking the medications.

Dr. Gary Foster, chief scientific officer at WeightWatchers, similarly said that offering medication was a"natural next step" for the company. "What these drugs have really shown us is that obesity is a metabolic biological problem. You can’t just overcome it with lifestyle interventions, for the most part," said Dr. Eduardo Grunvald, an obesity medicine physician at UC San Diego Health.

Dr. Spencer Nadolsky, Sequence's medical director, said some people have difficulties obtaining the drugs because some general practitioners are not yet comfortable prescribing them. "Taking these weight-loss medications has validated what I knew: that my body was working against me, and that I wasn’t broken," Wood said in an email.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 10. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인